Letters
Renaming low risk cancers
Renaming low risk cancers: honest engagement with patients is more important
BMJ 2019; 364 doi: https://doi.org/10.1136/bmj.l840 (Published 26 February 2019) Cite this as: BMJ 2019;364:l840
- Santhanam Sundar, consultant oncologist
- Nottingham University Hospitals NHS Trust, Nottingham, UK
- sundar{at}oncology.org
Renaming low risk cancers would be a cosmetic exercise and would not solve the underlying problem.1 The exponential rise in diagnosis of low risk cancers …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.